BackgroundTreating severe pneumonia caused by multiple pathogens in immunocompromised hosts (ICHs) presents significant challenges. Isavuconazole (ISA). a next-generation triazole antifungal agent. has shown promise in managing fungal infections. https://www.markbroyard.com/save-big-quest-mv40-gas-floor-fryer-40-lb-casters-natural-gas-discount-best-mega/